Arthrogenic muscle inhibition аfter anterior cruciate ligament rupture: a systematic review
Journal of Clinical Practice · 08.06.2026 · 17 (2) · 125-138
DOI: 10.17816/clinpract696935 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Clinical Practice, online erschienen am 08.06.2026. Verfasst von Dmitry V. Skvortsov und 2 weiteren Autor:innen. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Arthrogenic muscle inhibition is a major concern in modern sports traumatology and orthopedic surgery, considerably limiting functional recovery following anterior cruciate ligament reconstruction. Despite advancements in surgical techniques and rehabilitation programs, approximately half of patients do not achieve complete recovery and experience recurrent episodes of muscle weakness with reduced quadriceps strength and knee joint stability. The work aimed to provide a comprehensive review of existing research on neurophysiological mechanisms, clinical manifestations, and potential therapeutic interventions for arthrogenic muscle inhibition following anterior cruciate ligament reconstruction. A search of studies published between 2000 and 2024 was performed in PubMed, EMBASE, CINAHL, Cochrane Library, and Google Scholar. The search terms included arthrogenic muscle inhibition, anterior cruciate ligament reconstruction, quadriceps activation, and rehabilitation strategies. The final analysis included randomized controlled and observational studies that met strict inclusion criteria; single-arm studies, case reports, and animal experiments were excluded. An analysis of 70 publications found that arthrogenic muscle inhibition is reported in 43% of patients after anterior cruciate ligament reconstruction. It is associated with both impaired quadriceps activation and considerable alterations in spinal and supraspinal neurophysiological structures. Cryotherapy, neuromuscular electrical stimulation, and structured exercise programs demonstrated are moderately effective in reducing arthrogenic muscle inhibition in both the early and late postoperative periods. Transcranial magnetic stimulation is a promising therapeutic option. Following anterior cruciate ligament injury, early diagnosis of arthrogenic muscle inhibition and the determination of an adequate treatment strategy are essential. This improves reconstruction success rates and functional outcomes while reducing the long-term risk of recurrent injuries.
Zitieren
APA
Skvortsov, D. V., Gulyakovich, A. I., & Akhpashev, A. A. (2026). Arthrogenic muscle inhibition аfter anterior cruciate ligament rupture: a systematic review. Journal of Clinical Practice, 17(2), 125-138. https://doi.org/10.17816/clinpract696935
Vancouver
Skvortsov DV, Gulyakovich AI, Akhpashev AA. Arthrogenic muscle inhibition аfter anterior cruciate ligament rupture: a systematic review. Journal of Clinical Practice. 2026;17(2):125-138. doi:10.17816/clinpract696935
BibTeX
@article{Skvortsov2026,
author = {Skvortsov, Dmitry V. and Gulyakovich, Alexey I. and Akhpashev, Alexander A.},
title = {Arthrogenic muscle inhibition аfter anterior cruciate ligament rupture: a systematic review},
journal = {Journal of Clinical Practice},
year = {2026},
volume = {17},
number = {2},
pages = {125--138},
doi = {10.17816/clinpract696935}
}
EUVIMED